QUOTED. March 25, 2019. R. Kevin Plemmons.
Innovative Cardiovascular Solutions hopes to earn the CE mark and US FDA approval for its Emblok Embolic Protection System. See what the company's CEO, R. Kevin Plemmons, said about the technology here.
“By effectively protecting the brachiocephalic artery, we can protect the entire body – not only the critical three cerebral arteries -- but downstream as well to the abdominal and peripheral vasculature." –R. Kevin Plemmons, CEO, Innovative Cardiovascular Solutions
- Find out more: Start-Up Spotlight: Innovative Cardiovascular Solutions Hopes to Win Regulatory Nod for Embolic Protection For TAVR
Click here for a free trial of Medtech Insight